69
Growth Score
pts
Heat Score
-2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
537906
Pattern Pharma develops novel therapeutics that use the innate immune system to fight cancer and infectious disease.
Andrew Williams: Chief Financial OfficerPast Role: Cynapsus Therapeutics, Co-Founder, COO & CFO
About the Company
Pattern Pharma is a life sciences company that develops novel therapeutics that use the innate immune system to fight cancer and infectious disease. P2PAR, Pattern's lead product, is an immunotherapeutic that uses innate immune cells to kill cancer cells while also safely activating an efficacious innate and adaptive immune response,
overcoming many of the limitations of traditional therapies.
